SafetyDrugs, the safety database.
Solid. Sturdy. Secure.
Solid. Sturdy. Secure.
SafetyDrugs is the pharmacovigilance software that allows you to collect, manage, transmit and analyze adverse events from clinical studies
and post marketing surveillance, including literature cases, of all products: from drugs to medical devices, from vaccines to cosmetics.
The web-based application runs on Oracle database, our technology partner and leader in Relational Data Base Management System (RDBMS).
What is it?
SafetyDrugs is the safety database that simplifies your pharmacovigilance activities: suitable for collecting, managing, transmitting and analyzing all adverse events.
Why?
SafetyDrugs is more than a simple database:
it is the tool that helps your work and its management. Supplied with features and tools for you and your team.
How much?
SafetyDrugs is profitable for everyone:
it suits any reality, saving unnecessary costs. Build your database fitted to
real business needs.
Last news
AFI Symposium 2024: the latest from the pharmaceutical world
Discover the main themes of the AFI Symposium 2024, from sustainability to supply chain challenges, and explore the latest developments.
AFI Symposium 2024: the scientific sessions in the pharmaceutical sector
The AFI Symposium 2024, held from June 5 to 7 in Rimini, offers a significant opportunity for professionals in the pharmaceutical sector to stay updated. Here are the sessions.
Clinical Trials: what are they?
Clinical trials are a fundamental phase in the development of a therapy. We have gathered essential information worth knowing about them.